Articles

Apple scores win in court to pause Apple Watch ban

Post Content

Afraid rising cost of living will kill your retirement goals? You’re not alone  

New year, higher expenses? Rising cost of living is scaring some Americans looking to save for retirement.

Is this the end for high annuity yields?

If interest rates follow predictions and keep falling in 2024, you can expect annuity payout yields to plunge further, too.

Plug Power installs first hydrogen-producing system at an Amazon fulfillment center

Plug Power said Wednesday that it completed the first installation of an electrolyzer system at an Amazon fulfillment center.

Here’s the ‘magic number’ for mortgage rates that would ‘unfreeze the housing market’

Mortgage rates are falling — but with home prices hitting an all-time high, it's still not enough to revive the housing market, according to one expert.

11 dividend stocks with high yields expected to be well supported in 2024 per strict criteria

These companies' expected free cash flow yields are at least double their current dividend yields.

Cytokinetics’ stock rockets to 19-year high after positive data on heart-disease treatment

Cytokinetics' stock rocketed Wednesday, after the cardiovascular-biopharmaceutical company announced positive results from a Phase 3 trial of aficamten, a treatment for hypertrophic cardiomyopathy.

A record share of S&P 500 stocks have underperformed the index in 2023 as ‘weirdest bull market in decades’ marches on

The S&P 500 is closing in on a fresh record high as 2023 draws to a close. Unfortunately for stock pickers, many of the index's constituents remain well below their highs from January 2022.

The 10 days that moved the stock market the most in 2023

Here are the 5 biggest up days and 5 biggest down days for the S&P 500 this year.

New York Times files copyright-infringement suit against Microsoft and OpenAI

The New York Times on Wednesday filed a copyright lawsuit against Microsoft and ChatGPT creator OpenAI in a legal action expected to shape the debate over generative-artificial-intelligence technologies.

Fusion Pharma climbs as analysts flag radiopharmaceutical company as potential merger target

Targeted-oncology specialist draws upgrade at Raymond James after big premium paid is for Rayze Bio.

Small-cap stocks are nearing a ‘golden cross’ as year-end rally heats up

Post Content
1 1,812 1,813 1,814 1,815 1,816 2,502